Middle East Clinical Trial Regulatory Update: Pioneering Frameworks
The Middle East Town Hall at DIA Europe 2024 showcased significant Middle East clinical trial regulatory advancements across the...
AI’s Astonishing Impact on Drug Development and Ethics
The 2024 DIA Europe conference hosted a forward-thinking session titled “AI in Medicines Regulation: Beyond our Imagination.” The session...
Powerful Innovations in Medical Device Software at DIA Europe 2024
The 2024 DIA Europe Conference brought together industry experts to explore the rapidly evolving medical device software and connected...
In-Silico Breakthrough: EMA’s Shift from Animal Testing
The DIA Europe 2024 conference brought together leading experts to discuss groundbreaking innovations and regulatory strategies in clinical trials....
New Insights: International Clinical Trial Regulatory Innovation
At the recent Duke-Margolis Institute for Health Policy conference, regulatory experts worldwide gathered to discuss advancements and collaborative strategies...
Industry and FDA Insights on Clinical Trial Regulatory Change
At the Duke-Margolis Institute for Health Policy conference, industry and government leaders delved into the future of clinical trials...
FDA On Clinical Trial Innovation and Regulatory Evolution
The Enhancing Adoption of Innovative Clinical Trial Approaches: FDA Convening conference hosted by Duke Margolis Institute for Health Policy,...
Merck’s Approach to Protocol Development: Building with Purpose:
At the 2024 SCOPE Summit, Laura Galuchie, Senior Director and TransCelerate Program Lead at Merck provided a fresh perspective...
Abbvie Leads The Way With DHTs in Clinical Trials
At the 2024 SCOPE Summit, AbbVie’s Digital Science Head, Michelle Crouthamel, presented compelling case studies on Aleve PM and...
How Pfizer Uses AI to Transform Clinical Trial Data Oversight
At the 2024 SCOPE Summit, Demetris Zambas, VP and Global Head of Data Monitoring and Management at Pfizer explored...